Amoeba SA
PAR:ALMIB

Watchlist Manager

Amoeba SA

PAR:ALMIB

Watchlist

Dividends

Discount Rate

Price: 0.616 EUR 1.65%

Market Cap: 30.6m EUR

Have any thoughts about
Amoeba SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 0.616 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ALMIB Alert

Amoeba SA

0.616

+0.010 (+1.65%)

52 Week Range	0.371 0.629
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Amoeba SA

What unique competitive advantages
does Amoeba SA hold over its rivals?

What risks and challenges
does Amoeba SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Amoeba SA.

What unique competitive advantages
does Amoeba SA hold over its rivals?

What risks and challenges
does Amoeba SA face in the near future?

Has there been any significant insider trading activity
in Amoeba SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Amoeba SA.

Provide P/S
for Amoeba SA.

Provide P/E
for Amoeba SA.

Provide P/OCF
for Amoeba SA.

Provide P/FCFE
for Amoeba SA.

Provide P/B
for Amoeba SA.

Provide EV/S
for Amoeba SA.

Provide EV/GP
for Amoeba SA.

Provide EV/EBITDA
for Amoeba SA.

Provide EV/EBIT
for Amoeba SA.

Provide EV/OCF
for Amoeba SA.

Provide EV/FCFF
for Amoeba SA.

Provide EV/IC
for Amoeba SA.

Show me price targets
for Amoeba SA made by professional analysts.

What are the Revenue projections
for Amoeba SA?

How accurate were the past Revenue estimates
for Amoeba SA?

What are the Net Income projections
for Amoeba SA?

How accurate were the past Net Income estimates
for Amoeba SA?

What are the EPS projections
for Amoeba SA?

How accurate were the past EPS estimates
for Amoeba SA?

What are the EBIT projections
for Amoeba SA?

How accurate were the past EBIT estimates
for Amoeba SA?

Compare the revenue forecasts
for Amoeba SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amoeba SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amoeba SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amoeba SA compared to its peers.

Compare the P/E ratios
of Amoeba SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Amoeba SA with its peers.

Analyze the financial leverage
of Amoeba SA compared to its main competitors.

Show all profitability ratios
for Amoeba SA.

Provide ROE
for Amoeba SA.

Provide ROA
for Amoeba SA.

Provide ROIC
for Amoeba SA.

Provide ROCE
for Amoeba SA.

Provide Gross Margin
for Amoeba SA.

Provide Operating Margin
for Amoeba SA.

Provide Net Margin
for Amoeba SA.

Provide FCF Margin
for Amoeba SA.

Show all solvency ratios
for Amoeba SA.

Provide D/E Ratio
for Amoeba SA.

Provide D/A Ratio
for Amoeba SA.

Provide Interest Coverage Ratio
for Amoeba SA.

Provide Altman Z-Score Ratio
for Amoeba SA.

Provide Quick Ratio
for Amoeba SA.

Provide Current Ratio
for Amoeba SA.

Provide Cash Ratio
for Amoeba SA.

What is the historical Revenue growth
over the last 5 years for Amoeba SA?

What is the historical Net Income growth
over the last 5 years for Amoeba SA?

What is the current Free Cash Flow
of Amoeba SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amoeba SA.

P/B
Price to Book Value

-7.8

Current

4.2

Median

1.6

Industry

Lower than median

Lower than industry value

Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.

P/B

-7.8

Market Cap

30.4m EUR

Book Value of Equity

-3.9m EUR

All Countries

Forward Multiples

			Market Cap	P/B
FR		Amoeba SA PAR:ALMIB	30.4m EUR	-7.8
US		Sherwin-Williams Co NYSE:SHW	90.4B USD	21.7
JP		Shin-Etsu Chemical Co Ltd TSE:4063	11T JPY	2.3
US		Ecolab Inc NYSE:ECL	69.9B USD	8.2
CH		Givaudan SA SIX:GIVN	37.9B CHF	8.8
US		Dupont De Nemours Inc NYSE:DD	34.6B USD	1.5
CN		Wanhua Chemical Group Co Ltd SSE:600309	242.2B CNY	2.6
IN		Asian Paints Ltd NSE:ASIANPAINT	2.8T INR	15
CH	D	DSM-Firmenich AG AEX:DSFIR	28.8B EUR	1.3
US		PPG Industries Inc NYSE:PPG	28.9B USD	3.7
US		International Flavors & Fragrances Inc NYSE:IFF	25.4B USD	1.8


FR		Amoeba SA PAR:ALMIB	Average P/B: 6.7 Negative Multiple: -7.8
US		Sherwin-Williams Co NYSE:SHW	21.7
JP		Shin-Etsu Chemical Co Ltd TSE:4063	2.3
US		Ecolab Inc NYSE:ECL	8.2
CH		Givaudan SA SIX:GIVN	8.8
US		Dupont De Nemours Inc NYSE:DD	1.5
CN		Wanhua Chemical Group Co Ltd SSE:600309	2.6
IN		Asian Paints Ltd NSE:ASIANPAINT	15
CH	D	DSM-Firmenich AG AEX:DSFIR	1.3
US		PPG Industries Inc NYSE:PPG	3.7
US		International Flavors & Fragrances Inc NYSE:IFF	1.8

P/B Forward Multiples

Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/B

N/A

2-Years Forward

P/B

N/A

3-Years Forward

P/B

N/A

Amoeba SA
PAR:ALMIB

P/B
Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Amoeba SA PAR:ALMIB

P/B Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Amoeba SA
PAR:ALMIB

P/B
Price to Book Value